Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-24-051131·COSCIENS Biopharma Inc.
Schedule 13D ownership disclosure
Cosciens Biopharma Inc
Common stock, no par value · CUSIP: 22112H101
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Goodwood Fund
Shares: 257,257.00 · Class: 8.2%
- Goodwood Inc.Reported CIK 0001297339
Shares: 257,257.00 · Class: 8.2%
- Peter Puccetti
Shares: 257,257.00 · Class: 8.2%
- Puccetti Funds Management Inc.
Shares: 257,257.00 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-051131
- Form type
- SCHEDULE 13D/A
- Filer
- COSCIENS Biopharma Inc.
- CIK
- CIK 1113423
- Filed
- Dec 20, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13D beneficial ownership